Francesca A. Wilkins, M.D.
NPI 1801061486ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Southaven, MS
Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Southaven, Mississippi, trained at University of Mississippi School of Medicine (class of 2005). Their prescriptions cost Medicare Part D more than their services did: $147,120 for 468 claims, against $734.17 paid for services in 2024. Novo Nordisk Inc was the largest of 5 companies reporting payments in 2025, $249.92 in all, mostly food and beverage.
Overview
| NPI | 1801061486 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 24, 2008 |
| Last updated in NPPES | Dec 21, 2023 |
| Certified by provider | Dec 21, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 20363 | MS |
| Internal Medicine | 207R00000X | 20363 | MS |
| Internal Medicine | 207R00000X | MD.204476 | LA |
| Internal Medicine | 207R00000X | N7510 | TX |
| Internal Medicine, Endocrinology, Diabetes & Metabolism | 207RE0101X | 40663 | SC |
| Internal Medicine, Endocrinology, Diabetes & Metabolism | 207RE0101X | E-8277 | AR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (MS) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 16 |
|---|---|
| Services billed | 57 across 8 procedure codes |
| Paid by Medicare | $734.17 |
Part D prescriptions in 2024
| Prescriptions (claims) | 468 · 1,134 30-day fills |
|---|---|
| Patients | 68 |
| Total drug cost | $147,120 |
| Generic share | 62% of claims |
Education and affiliations
| Medical school | University of Mississippi School of Medicine |
|---|---|
| Graduation year | 2005 |
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
Medical groups
- Wayne General HospitalWaynesboro, MS · 47 clinicians
- Northeast Mississippi Health Care IncByhalia, MS · 11 clinicians
Hospital affiliation
- Wayne General HospitalWaynesboro, MS
Industry payments (Open Payments)
- 2025$249.92 · 6 payments from 5 companies
- 2024$227.44 · 6 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $125.00 | 1 |
| Corcept Therapeutics | $41.54 | 2 |
| Rgh Enterprises LLC | $29.84 | 1 |
| Sequel Med Tech, LLC | $27.67 | 1 |
| Insulet Corporation | $25.87 | 1 |
What the 2025 payments were for
- Food and Beverage$249.92 · 6 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Southaven
- 1538430244
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Mississippi →